ArticleEnvironmental health and preventive medicine2026
Impact of aldehyde dehydrogenase 2 polymorphism on lipid profile alterations in alcohol-abstinent adolescents stratified by steatotic liver disease status.
Article in Environmental health and preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSingle-nucleotide polymorphism in aldehyde dehydrogenase 2 (ALDH2) is associated with metabolic dysfunction-associated steatotic liver disease (MASLD). However, this association in alcohol-abstinent individuals remains unknown. We assessed SLD and genotype-inferred ALDH2 activity (ALDH2 activity) in alcohol-abstinent adolescents to explore the association between ALDH2 activity and metabolism-related factors stratified by SLD status.
methodsIn this cross-sectional study, 253 university students (<20 years; 162 males, 91 females) underwent first-year health screening including abdominal ultrasonography and genotyping for ALDH2 rs671, categorized as a high-activity genotype (GG) or reduced-activity genotype (non-GG). The associations of metabolism-related parameters were analyzed across SLD and ALDH2 genotype groups, and predictive performance was assessed using ROC analysis.
resultsWe focused on significant changes in metabolism-related parameters, particularly in adolescent males, due to their higher prevalence of SLD. Increased preperitoneal fat and aspartate aminotransferase levels and decreased high-density lipoprotein cholesterol (HDL-C) levels were observed in the non-SLD group, with high ALDH2 activity; low-density lipoprotein cholesterol (LDL-C) levels in the SLD group increased in high ALDH2 activity. In stratified analyses, univariate and multivariate logistic regression revealed that, among adolescents without SLD, those with the GG genotype had significantly lower HDL-C levels (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.91-0.99, p = 0.016). Conversely, among adolescents with SLD, the high-activity GG genotype was associated with significantly higher LDL-C levels (OR, 1.03; 95% CI, 1.01-1.05, p = 0.001). Exploratory cutoffs for HDL-C (<64 mg/dL) and LDL-C (≥114 mg/dL) showed moderate discriminatory ability (AUC 0.727 and 0.701, respectively) and showed modest genotype-classification performance in an independent cohort.
conclusionsThe association between ALDH2 rs671 genotype and lipid profiles differed according to SLD status under non-alcoholic conditions. Combined assessment of SLD and lipid changes may provide an exploratory approach for estimating ALDH2 genotype-inferred alcohol-metabolizing capacity in adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.